Correlation between immune signature and high‐density lipoprotein cholesterol level in stage II/III colorectal cancer-Reference-Cited by-同舟云学术

Correlation between immune signature and high‐density lipoprotein cholesterol level in stage II/III colorectal cancer

Published:2019-02-07 Issue:3 Volume:8 Page:1209-1217
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Wang Yun¹²³,Sun Xiao‐qiang⁴,Lin Hao‐cheng¹³,Wang De‐shen¹³,Wang Zhi‐qiang¹³,Shao Qiong¹⁵,Wang Feng‐hua¹³,Yan Shu‐mei¹⁶,Liang Jie‐ying¹³,Zeng Zhao‐lei¹,Ju Huai‐qiang¹,Xu Rui‐hua¹³^ORCID,Li Yu‐hong¹³^ORCID

Affiliation:

1. Sate key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine Sun Yat‐sen University Cancer Center Guangzhou P.R. China

2. Department of Hematologic Oncology Sun Yat‐sen University Cancer Center Guangzhou P.R. China

3. Department of Medical Oncology Sun Yat‐sen University Cancer Center Guangzhou P.R. China

4. Key Laboratory of Tropical Disease Control Chinese Ministry of Education Zhong‐shan School of Medicine Sun Yat‐sen University Guangzhou P.R. China

5. Department of Molecular Diagnostics Sun Yat‐sen University Cancer Center Guangzhou P.R. China

6. Department of Pathology Sun Yat‐sen University Cancer Center Guangzhou P.R. China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.1987

Reference30 articles.

1. Cancer statistics in China, 2015

2. Analysis and prediction of colorectal cancer incidence trend in China;Dai Z;Zhonghua Yu Fang Yi Xue Za Zhi,2012

3. Clinical Significance of Circulating Tumor Cells, Including Cancer Stem-Like Cells, in Peripheral Blood for Recurrence and Prognosis in Patients With Dukes' Stage B and C Colorectal Cancer

4. Colorectal cancer screening and surveillance: Clinical guidelines and rationale?Update based on new evidence

5. Baseline and On-Treatment High-Density Lipoprotein Cholesterol and the Risk of Cancer in Randomized Controlled Trials of Lipid-Altering Therapy

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nomogram incorporating preoperative pan-immune-inflammation value and monocyte to high-density lipoprotein ratio for survival prediction in patients with colorectal cancer: a retrospective study;BMC Cancer;2024-06-17

2. Lipid Profiles Impact on the Oncologic Outcome of Upper Tract Urothelial Carcinoma;World Journal of Oncology;2024-04

3. Correlation Analysis of Blood Lipid Level and Thyroid Tumors;2024-03-29

4. Cholesterol induction in CD8+ T cell exhaustion in colorectal cancer via the regulation of endoplasmic reticulum-mitochondria contact sites;Cancer Immunology, Immunotherapy;2023-11-03

5. A Combination of Enteral Nutritional Support and Induction Therapy Elevates Blood Lipids, Improves Nutritional Status, and Increases Longer Overall Survival in Acute Myeloid Leukemia;Current Topics in Nutraceutical Research;2023-09-09